コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 farction, or one cardiovascular death or one coronary revascularization procedure).
2 thrombotic complications after percutaneous coronary revascularization procedures.
3 ages for 'fast tracking' patients undergoing coronary revascularization procedures.
4 f 60 years and at least 1 sibling with MI or coronary revascularization procedures.
5 erm survival after percutaneous and surgical coronary revascularization procedures.
6 infarction, and patients undergoing elective coronary revascularization procedures.
7 ardial infarction or stroke, or the need for coronary-revascularization procedures.
8 events; RR, 0.68; 95% CI, 0.49-0.95; P=.02), coronary revascularization procedures (157 vs 106 proced
9 , 333 (29%) first events occurred (70 AF, 67 coronary revascularization procedures, 65 CHF, 48 MI, 38
10 is of the use of cardiac catheterization and coronary revascularization procedures after AMI in milit
11 nts hospitalized from 1995 to 1998 for first coronary revascularization procedures after renal replac
13 healthcare reform in Massachusetts on use of coronary revascularization procedures and in-hospital an
14 Recurrent MI, CHD events (recurrent MI or a coronary revascularization procedure), and mortality wer
15 myocardial infarction (MI), unrecognized MI, coronary revascularization procedures, angina pectoris,
16 tory to maximal medical therapy and standard coronary revascularization procedures are diagnosed each
17 s to apply a new method to determine whether coronary revascularization procedures are underused, esp
18 death, Q-wave myocardial infarction and any coronary revascularization procedure) at one year was si
19 fies all Medicare beneficiaries undergoing a coronary revascularization procedure: coronary artery by
20 ous studies have shown that women undergoing coronary revascularization procedures do so at a higher
21 Reducing insurance barriers to receipt of coronary revascularization procedures has not yet elimin
22 ation of CVD (myocardial infarction, angina, coronary revascularization procedure, heart failure, or
23 nts is currently the most commonly performed coronary revascularization procedure; hence, optimizing
24 0.5 mg/d was due primarily to lower risks of coronary revascularization procedures, hospitalization f
25 improve prognosis in patients who have had a coronary revascularization procedure (i.e., percutaneous
26 spective trials of surgical and percutaneous coronary revascularization procedures in dialysis patien
28 onary artery disease, and that many elective coronary revascularization procedures may be unnecessary
31 nd = 0.61), and was directly associated with coronary revascularization procedures (OR = 2.38, 95% CI
32 her than expected rates of valve surgery and coronary revascularization procedures over the next 10 t
33 P=0.009) and required a higher rate of late coronary revascularization procedures (PCI: Mod-CAD vs.
34 on the trends in the volume and outcomes of coronary revascularization procedures performed on Medic
35 These findings should influence the type of coronary revascularization procedure selected for patien
36 rs were substantially less likely to undergo coronary revascularization procedures than those without
37 dies have reported that blacks undergo fewer coronary-revascularization procedures than whites, but i
38 e use of aspirin, beta-blockers, statins, or coronary-revascularization procedures was lowest in this
39 g death, myocardial infarction [MI], and any coronary revascularization procedure) was significantly
40 ndary end point, which included undergoing a coronary revascularization procedure, was determined as
41 nts hospitalized from 1995 to 1999 for first coronary revascularization procedure were retrospectivel
42 up in the incidence of secondary outcomes of coronary revascularization procedures, worsening heart f
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。